FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.3  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely rofecoxib 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pilocarpine hydrochloride 20 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diamorphine hydrochloride 10 milligram/1 ampule powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cerivastatin sodium 300 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely etoricoxib 60 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fosinopril sodium 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely methenamine hippurate 1 gram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely olanzapine 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely daunorubicin (as daunorubicin hydrochloride) 20 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin sodium) 250 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely oseltamivir (as oseltamivir phosphate) 75 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely didanosine 400 milligram/1 each gastro-resistant oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sodium nitroprusside dihydrate 50 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely eplerenone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely imidapril hydrochloride 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lorazepam 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fexofenadine hydrochloride 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pantoprazole (as pantoprazole sodium sesquihydrate) 40 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely valproic acid 150 milligram/1 each gastro-resistant oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely gabapentin 600 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluoxetine (as fluoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zaleplon 10 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fluticasone propionate 500 microgram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely afatinib dimaleate 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely terbinafine (as terbinafine hydrochloride) 10 milligram/1 gram conventional release cutaneous solution Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely econazole nitrate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely citalopram (as citalopram hydrobromide) 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pilocarpine hydrochloride 40 milligram/1 gram conventional release eye gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely teriflunomide 14 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely estradiol valerate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zolmitriptan 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely perampanel 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely levetiracetam 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prasugrel 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely fusidic acid 50 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely dehydroepiandrosterone 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely eltrombopag 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trandolapril 4 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely botulinum toxin type A 500 unit/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely folinic acid 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ramipril 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely morphine sulfate 20 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lamivudine 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely zotepine 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lisuride 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely chlortalidone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefuroxime (as cefuroxime axetil) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely diazepam 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely vancomycin (as vancomycin hydrochloride) 125 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely simvastatin 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lamotrigine 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely amantadine hydrochloride 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely medroxyprogesterone acetate 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tiabendazole 100 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely mexiletine hydrochloride 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely sucralfate 200 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely olanzapine 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely meloxicam 15 milligram/1 each conventional release rectal suppository Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely lacosamide 200 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely prednisone 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely vardenafil hydrochloride 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely chloramphenicol 100 milligram/1 milliliter conventional release ear drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hypromellose 10 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely alendronic acid 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely trientine 300 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely doxepin (as doxepin hydrochloride) 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely clonidine hydrochloride 100 microgram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tibolone 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely hypromellose 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely azelaic acid 150 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ciclosporin 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely temazepam 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely tamoxifen 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely vardenafil hydrochloride 20 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Product containing precisely ramipril 1.25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 248 of 342 Next End

    This concept is not in any reference sets

    Back to Start